# The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN

> **NCT05631717** · PHASE3 · UNKNOWN · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 40 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus
- Lupus Nephritis

## Interventions

- **BIOLOGICAL:** Human umbilical cord mesenchymal stem cells
- **DRUG:** Interleukin-2

## Key facts

- **NCT ID:** NCT05631717
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2025-06
- **Final completion:** 2025-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05631717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05631717, "The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05631717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*